openPR Logo
Press release

Knee Osteoarthritis Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Abbvie, Amzell, AstraZeneca, BioIntegrate, Bioventus, Celltex, Centrexion, Eli Lilly, Eupraxia, Sclnow

10-16-2023 05:51 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Knee Osteoarthritis Pipeline Analysis (2023) Covering

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, about 40+ key pharma and biotech companies are working on 40+ pipeline drugs in the Knee Osteoarthritis therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.

"Knee Osteoarthritis Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Knee Osteoarthritis Therapeutics Market.

The report provides a detailed description of the Knee Osteoarthritis drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.

Get a Detailed Overview of the Knee Osteoarthritis Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/report-store/knee-osteoarthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Knee Osteoarthritis Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Knee Osteoarthritis therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Knee Osteoarthritis treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Knee Osteoarthritis drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Knee Osteoarthritis treatment market.

Learn More about the Clinical and Commercial Development Activities in the Knee Osteoarthritis Therapeutics Domain @
https://www.delveinsight.com/report-store/knee-osteoarthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Knee Osteoarthritis (OA) Therapeutics Analysis
Currently, there are several pharmacologic treatments available for the management of knee Knee osteoarthritis-related pain and for improving its functionality. These common pharmacologic interventions used to help alleviate the symptoms of knee Knee Osteoarthritis include nonsteroidal anti-inflammatory drugs (NSAIDs), intra-articular corticosteroids, intra-articular hyaluronic acid, and well as opioids. Non-pharmacological therapies should always be attempted as the first line of treatment for Knee osteoarthritis like, exercise, weight management, and adjunct therapies. Historically, cyclooxygenase inhibitors (acetaminophen and NSAIDs) have been the most commonly used medications after non-pharmacological therapies. Further opioids, corticoids, and visco supplements are used for the treatment of Knee Osteoarthritis

HA injections, provide viscous lubrication, have shocking absorbing properties, and additionally, possible anti-inflammatory and anti-oxidant functions have been described. Currently, Durolane, Gelsyn-3, Cingal, Monovisc, and other hyaluronic acid (HA) formulations are available in the market for the treatment of Knee Osteoarthritis.

To further improve the treatment scenario, there are approx. 40+ key companies developing therapies for Knee osteoarthritis. Currently, Bone Therapeutics is leading the therapeutics market with its Knee osteoarthritis drug candidates in the most advanced stage of clinical development.

On 13 June 2023, Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) announced that the U.S. Food and Drug Administration ("FDA") has granted Fast Track designation for the investigation of EP-104IAR in the treatment of adults with osteoarthritis ("OA") of the knee.

Expected launch of potential therapies by key players like Techfields (X0002), Taiwan Liposome Company (TLC599), Centrexion Therapeutics (CNTX-4975), Biosplice Therapeutics (Lorecivivint), Ampio Pharmaceuticals (Ampion), Paradigm Biopharmaceuticals (Zilosul), Grünenthal (RTX-GRT7039/Resiniferatoxin), Naturecell (JointStem), and others may improve the treatmnet outcome and the increase the market size in the coming years, assisted by an increase in the prevalent population of Knee Osteoarthritis.

Knee Osteoarthritis Companies in the Therapeutics Market Include:
Abbvie, Akan Biosciences, Ampio Pharmaceuticals, Amzell, Anika Therapeutics, AstraZeneca, BioIntegrate, Bioventus LLC, Bone Therapeutics, CAR-T (Shanghai) Biotechnology, Celltex Therapeutics Corporation, Centrexion Therapeutics, Eli Lilly and Company, Eupraxia Pharmaceuticals, Flexion Therapeutics, Galapagos NV, Gwo Xi Stem Cell Applied Technology, Meluha Life Sciences SDN BHD, Mestex AG, Mitsubishi Tanabe Pharma Corporation, Moebius Medical, Novartis, Orient Europharma Co., Ltd., OrthoTrophix, Paradigm Biopharmaceuticals, Peptinov SAS, Personalized Stem Cells, Propella Therapeutics, PT. Prodia Stem Cell Indonesia, Purdue Pharma, R-Bio, Regeneron Pharmaceuticals, Samumed LLC, Sclnow Biotechnology, Sorrento Therapeutics, Swiss Medica XXI Century S.A., Taiwan Liposome Company, Techfields Pharma, UnicoCell Biomed CO. LTD, Vivex Biomedical, Xalud Therapeutics, Yooyoung Pharmaceutical, and many others.

Emerging and Marketed Knee Osteoarthritis Therapies Covered in the Report Include:
• JTA-004: Bone Therapeutics
• MM-II: Moebius Medical
And Many More

Get an in-depth Assessment of the Emerging Therapies and Knee Osteoarthritis Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/knee-osteoarthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

The Report Covers the Emerging Knee Osteoarthritis Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates

Route of Administration
Knee osteoarthritis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical

Molecule Type
Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy

Request for Sample PDF to Understand More About the Knee Osteoarthritis Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/knee-osteoarthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content
1. Report Introduction
2. Executive Summary
3. Knee Osteoarthritis Current Treatment Patterns
4. Knee Osteoarthritis - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Knee Osteoarthritis Late-Stage Products (Phase-III)
7. Knee Osteoarthritis Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Knee Osteoarthritis Discontinued Products
13. Knee Osteoarthritis Product Profiles
14. Knee Osteoarthritis Companies
15. Knee Osteoarthritis Drugs
16. Dormant and Discontinued Products
17. Knee Osteoarthritis Unmet Needs
18. Knee Osteoarthritis Future Perspectives
19. Knee Osteoarthritis Analyst Review
20. Appendix
21. Report Methodology

Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/knee-osteoarthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research

Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices

Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology

Other Trending Healthcare Reports by DelveInsight
Tenosynovitis Market
https://www.delveinsight.com/report-store/tenosynovitis-market

Checkpoint Inhibitor Refractory Cancer Market
https://www.delveinsight.com/report-store/checkpoint-inhibitor-refractory-cancer-market

Encephalomyelitis Market
https://www.delveinsight.com/report-store/encephalomyelitis-market

FENEBRUTINIB Market
https://www.delveinsight.com/report-store/fenebrutinib-emerging-insight-and-market-forecast

Non-Muscle Invasive Bladder Cancer Market
https://www.delveinsight.com/report-store/non-muscle-invasive-bladder-cancer-market

Nrg1 Fusion Cancer Pipeline Insight
https://www.delveinsight.com/report-store/nrg1-fusion-cancer-pipeline-insight

Acute Pyelonephritis Market
https://www.delveinsight.com/report-store/acute-pyelonephritis-market

Chronic Refractory Gout Market
https://www.delveinsight.com/report-store/chronic-refractory-gout-market

Complicated Urinary Tract Infections Market
https://www.delveinsight.com/report-store/complicated-urinary-tract-infections-market

Congestive Heart Failure (CHF) Market
https://www.delveinsight.com/report-store/congestive-heart-failure-market

Glomerulonephritis Market
https://www.delveinsight.com/report-store/glomerulonephritis-market

Metastatic Uveal Melanoma (MUM) Market
https://www.delveinsight.com/report-store/metastatic-uveal-melanoma-mum-market

Musculoskeletal Pain Market
https://www.delveinsight.com/report-store/musculoskeletal-pain-market

Recurrent Head And Neck Cancer Squamous Cell Carcinoma Market
https://www.delveinsight.com/report-store/recurrent-head-and-neck-cancer-squamous-cell-carcinoma-market

Dysthymia Market
https://www.delveinsight.com/report-store/dysthymia-market

Limb Girdle Muscular Dystrophy (LGMD) Market
https://www.delveinsight.com/report-store/limb-girdle-muscular-dystrophy-lgmd-market

Lower-Limb Spasticity Market
https://www.delveinsight.com/report-store/lower-limb-spasticity-market

Hemiplegia Market
https://www.delveinsight.com/report-store/hemiplegia-market

Global Kinase Inhibitor in Autoimmune Diseases Market
https://www.delveinsight.com/report-store/global-kinase-inhibitor-in-autoimmune-diseases-market

Hereditary Spastic Paraplegias Market
https://www.delveinsight.com/report-store/hereditary-spastic-paraplegias-market

Amebiasis Market
https://www.delveinsight.com/report-store/amebiasis-market

Galactosemia Market
https://www.delveinsight.com/report-store/galactosemia-market

Generalized Pustular Psoriasis Market
https://www.delveinsight.com/report-store/generalized-pustular-psoriasis-market

Hepatic Impairment Market
https://www.delveinsight.com/report-store/hepatic-impairment-market

Tuberous Sclerosis Complex Market
https://www.delveinsight.com/report-store/tuberous-sclerosis-complex-market

Amyloidosis Market
https://www.delveinsight.com/report-store/amyloidosis-market

BRAF-Mutant Metastatic Melanoma Market
https://www.delveinsight.com/report-store/braf-mutant-metastatic-melanoma-market

Candidemia Market
https://www.delveinsight.com/report-store/candidemia-market

Hepatitis D Market
https://www.delveinsight.com/report-store/hepatitis-d-market

Hyperkalemia Market
https://www.delveinsight.com/report-store/hyperkalemia-market

Vasomotor symptoms (Hot flashes/Night sweats) Market
https://www.delveinsight.com/report-store/vasomotor-symptoms-market

Balloon Valvuloplasty Device Market
https://www.delveinsight.com/report-store/balloon-valvuloplasty-market

Choroideremia Market
https://www.delveinsight.com/report-store/choroideremia-market

Chronic Hand Eczema Market
https://www.delveinsight.com/report-store/chronic-hand-eczema-market

Complex Regional Pain Syndrome Market
https://www.delveinsight.com/report-store/complex-regional-pain-syndrome-crps-market

Diffuse Large B-cell Lymphoma Market
https://www.delveinsight.com/report-store/diffuse-large-b-cell-lymphoma-market

Hypersomnia Market
https://www.delveinsight.com/report-store/hypersomnia-market

Lamellar Ichthyosis (LI) Market
https://www.delveinsight.com/report-store/lamellar-ichthyosis-market

Ulcerative Colitis (UC) Market
https://www.delveinsight.com/report-store/ulcerative-colitis-uc-market

Vernal Keratoconjunctivitis Market
https://www.delveinsight.com/report-store/vernal-keratoconjunctivitis-market-insight

Endocarditis Market
https://www.delveinsight.com/report-store/endocarditis-market

Essential Thrombocythemia (ET) Market
https://www.delveinsight.com/report-store/essential-thrombocythemia-et-market-insights

Hepatorenal Syndrome Market
https://www.delveinsight.com/report-store/hepatorenal-syndrome-market

Pancreatic Ductal Carcinoma Market
https://www.delveinsight.com/report-store/pancreatic-ductal-carcinoma-market

Tenosynovial Giant Cell Tumors (TSGCTs) Market
https://www.delveinsight.com/report-store/tenosynovial-giant-cell-tumors-tsgcts-market

Trauma Fixation Devices Market
https://www.delveinsight.com/report-store/trauma-devices-market

Usher Syndrome Market
https://www.delveinsight.com/report-store/usher-syndrome-market

Vulvar Squamous Cell Carcinoma Market
https://www.delveinsight.com/report-store/vulvar-squamous-cell-carcinoma-market

Wide Neck Bifurcation Intracranial Aneurysms Market
https://www.delveinsight.com/report-store/wide-neck-bifurcation-intracranial-aneurysms-market

Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Knee Osteoarthritis Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Abbvie, Amzell, AstraZeneca, BioIntegrate, Bioventus, Celltex, Centrexion, Eli Lilly, Eupraxia, Sclnow here

News-ID: 3251864 • Views:

More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market

All 5 Releases


More Releases for Knee

Knee Pain Relief Codes: The Ultimate Guide to Overcoming Knee Pain Naturally
The Knee Pain Relief Codes is a comprehensive online program designed to help individuals prevent and alleviate knee pain through proactive and natural methods. It provides valuable information on maintaining knee health, strengthening knee joints, and managing pain effectively. The program focuses on relieving joint discomfort, stiffness, and knee osteoarthritis using simple yet powerful exercises and techniques. While knee pain is common, some conditions like knee osteoarthritis and joint injuries can
Nooro Knee Massager Reviews 2024: How Does Nooro Knee Massager Work? Important U …
Nooro Knee Massager Reviews 2024: How Does Nooro Knee Massager Work? Important Update About Nooro Knee Massager, Buyers Beware!!! Introducing the groundbreaking Nooro Knee Massager - a cutting-edge solution meticulously designed by leading knee pain experts. Experience unparalleled relief precisely when you need it, as this revolutionary device combines Red Light Therapy, Heat Therapy, and Massage Therapy for a holistic approach to knee discomfort. Not only is it remarkably cost-effective, but
NOORO KNEE MASSAGER REVIEW 2023: BUYERS BEWARE! IS NOORO KNEE MASSAGER LEGIT?
In a world where knee discomfort has become increasingly prevalent, seeking effective solutions for pain relief has never been more important. Middle-aged and older individuals, in particular, often find themselves grappling with knee pain, hindering their daily activities and overall quality of life. This is where the Nooro Knee Massager steps in as a beacon of hope, offering targeted relief and relaxation for weary and sore knees. In this comprehensive
Knee Walker Market - Revolutionizing Rehabilitation: Knee Walker's Impact on the …
Newark, New Castle, USA: The "Knee Walker Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Knee Walker Market: https://www.growthplusreports.com/report/knee-walker-market/8893 This latest report researches the industry structure, sales, revenue,
Knee Sleeve Review 2022: (Must Read!) Is Knee Sleeve Working or Fake?
As people become older, the lubrication that surrounds their knee caps wears off, making them more susceptible to injury. The pain may eventually become intolerable with long-distance walking, frequent use of the knee, particularly on rough surfaces, and other daily activities. When this happens, a person can discover that they are unable to continue with their regular routines. To solve this problem, get our Knee Sleeves and use them in
Knee Orthosis Market Increasing Demand By Type: With Knee Pads, Knee Has Opening …
Acumen Research and Consulting has announced the addition of the "Knee Orthosis Market” report to their offering. The Knee Orthosis Market Report 2018 is an in depth study analyzing the current state of the Knee Orthosis Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Knee Orthosis Market provides analysis of China market covering the industry trends, recent